株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の体外診断(IVD)市場の分析

Analysis of the Global In Vitro Diagnostics Market

発行 Frost & Sullivan 商品コード 269959
出版日 ページ情報 英文 154 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界の体外診断(IVD)市場の分析 Analysis of the Global In Vitro Diagnostics Market
出版日: 2014年07月22日 ページ情報: 英文 154 Pages
概要

世界の体外診断(IVD)市場は、堅調に推移しています。2013年の市場規模は473億米ドルで、2017年には626億米ドルに達し、CAGRで7.3%の成長が見込まれています。

当レポートでは、世界の体外診断(IVD)市場について調査分析し、市場概要、促進要因・抑制要因、予測と動向、市場シェアと競合分析などについて、市場全体/セグメント別に、体系的な情報を提供しています。

本調査で扱っている内容

  • 成長している部門は?その成長はどれくらい続くのか?成長率は?
  • 競合企業が成長を維持するのに主要な戦略は?
  • 主要なM&A取引は?
  • 世界/新興市場における主な促進要因と抑制要因は?
  • 地域別市場の配分は?急成長している地域は?
  • 次世代シーケンス(NGS)に続く、新しい技術は?

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場概要 - 定義
  • 市場区分

第3章 外部の課題:促進要因と抑制要因 - 総合IVD市場

  • 市場促進要因
  • 促進要因の内容
  • 市場抑制要因
  • 抑制要因の内容
  • 新興市場に注目 - 市場促進要因
  • 新興市場に注目 - 市場抑制要因

第4章 予測と動向 - 総合IVD市場

  • 評価
  • 総合IVD市場 - 収益予測
  • 収益予測の考察

第5章 市場シェアと競合分析 - 総合IVD市場

  • 競合情勢
  • 市場シェア分析
  • 競合環境
  • 競合要因 - M&A

第6章 免疫化学検査

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 競合環境
  • 設置台数
  • 製品分析
  • 製品リスト
  • 共通検査

第7章 血糖自己測定(SMBG)

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 市場シェア分析
  • 競合環境
  • 製品リスト

第8章 ポイントオブケア(POC)検査

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 市場シェア分析
  • 競合環境

第9章 分子診断

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 市場シェア分析
  • 競合環境
  • 製品リスト

第10章 血液検査

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 市場シェア分析
  • 競合環境
  • 設置台数
  • 製品リスト

第11章 臨床微生物検査

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 市場シェア分析
  • 競合環境
  • 技術動向

第12章 止血検査

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 市場シェア分析
  • 競合環境
  • 検査
  • 製品リスト

第13章 組織診断

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 収益予測の考察
  • 競合分析 - 市場シェア
  • 競合構造

第14章 地域別

  • 収益率の予測:地域別
  • 地域の成長率
  • 米国の収益予測
  • 西欧の収益予測
  • アジア太平洋地域の収益予測
  • ブラジルの収益予測
  • 東欧の収益予測
  • その他の地域の収益予測

第15章 まとめ

第16章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: NE3E-01-00-00-00

Slowing US and European Markets Demand Alignment with Global Market Needs

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, companies are heavily focused on globalization in emerging economies such as China and Brazil. This research service discusses the IVD segments of immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose.

Key Questions This Study Will Answer

  • Which segments of the market are growing, how long will they continue to grow, and at what rate?
  • What primary strategies are competitors employing to sustain growth?
  • What do the key M&A deals indicate about the market?
  • What are the drivers and restraints for the global IVD market and for emerging markets?
  • What percentage does each region contribute to the global IVD market? Which regions are growing the fastest?
  • Which new technologies following next-generation sequencing (NGS) have the potential to be IVD applications?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Executive Summary
  • 2. Executive Summary (continued)
  • 3. Executive Summary (continued)
  • 4. Scope and Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Methodology

2. MARKET OVERVIEW

Market Overview

  • 1. Market Overview-Definitions
  • 2. Market Segmentation

3. EXTERNAL CHALLENGES: DRIVERS AND RESTRAINTS-TOTAL IVD MARKET

External Challenges: Drivers and Restraints-Total IVD Market

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Drivers Explained (continued)
  • 6. Market Restraints
  • 7. Restraints Explained
  • 8. Restraints Explained (continued)
  • 9. Restraints Explained (continued)
  • 10. Restraints Explained (continued)
  • 11. Focus on Emerging Markets-Market Drivers
  • 12. Focus on Emerging Markets-Market Restraints

4. FORECASTS AND TRENDS-TOTAL IVD MARKET

Forecasts and Trends-Total IVD Market

  • 1. Measurements
  • 2. Measurements (continued)
  • 3. Total IVD Market-Revenue Forecast
  • 4. Revenue Forecast Discussion

5. MARKET SHARE AND COMPETITIVE ANALYSIS- TOTAL IVD MARKET

Market Share and Competitive Analysis- Total IVD Market

  • 1. Competitive Analysis-Market Share
  • 2. Market Share Analysis
  • 3. Competitive Environment
  • 4. Competitive Factors-Mergers & Acquisitions

6. IMMUNOCHEMISTRY SEGMENT BREAKDOWN

Immunochemistry Segment Breakdown

  • 1. Immunochemistry Segment-Overview
  • 2. Immunochemistry Segment-Market Engineering Measurements
  • 3. Immunochemistry Segment-Revenue Forecast
  • 4. Immunochemistry Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Competitive Analysis-Market Share (continued)
  • 7. Immunochemistry Segment-Competitive Environment
  • 8. Immunochemistry Segment-Installed Base
  • 9. Immunochemistry Segment-Product Analysis
  • 10. Immunochemistry Segment-Product Analysis (continued)
  • 11. Immunochemistry Segment-Product List
  • 12. Immunochemistry Segment-Product List (continued)
  • 13. Immunochemistry Segment-Product List (continued)
  • 14. Immunochemistry Segment-Common Tests
  • 15. Immunochemistry Segment-Common Tests (continued)

7. SELF-MONITORING BLOOD GLUCOSE SEGMENT BREAKDOWN

Self-monitoring Blood Glucose Segment Breakdown

  • 1. SMBG Segment-Overview
  • 2. SMBG Segment-Market Engineering Measurements
  • 3. SMBG Segment-Revenue Forecast
  • 4. SMBG Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. SMBG Segment-Competitive Environment
  • 8. SMBG Segment-Product List

8. POINT-OF-CARE TESTING SEGMENT BREAKDOWN

Point-of-care Testing Segment Breakdown

  • 1. POCT Segment-Overview
  • 2. POCT Segment-Market Engineering Measurements
  • 3. POCT Segment-Revenue Forecast
  • 4. POCT Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. POCT Segment-Competitive Environment

9. MOLECULAR DIAGNOSTICS SEGMENT BREAKDOWN

Molecular Diagnostics Segment Breakdown

  • 1. Molecular Diagnostics Segment-Overview
  • 2. Molecular Diagnostics Segment-Overview (continued)
  • 3. Molecular Diagnostics Segment-Market Engineering Measurements
  • 4. Molecular Diagnostics Segment-Revenue Forecast
  • 5. Molecular Diagnostics Segment-Revenue Forecast Discussion
  • 6. Competitive Analysis-Market Share
  • 7. Market Share Analysis
  • 8. Molecular Diagnostics Segment-Competitive Environment
  • 9. Molecular Diagnostics Segment-Tests
  • 10. Molecular Diagnostics Segment-Product List
  • 11. Molecular Diagnostics Segment-Product List (continued)
  • 12. Molecular Diagnostics Segment-Product List (continued)
  • 13. Molecular Diagnostics Segment-Product List (continued)

10. HEMATOLOGY SEGMENT BREAKDOWN

Hematology Segment Breakdown

  • 1. Hematology Segment-Overview
  • 2. Hematology Segment-Market Engineering Measurements
  • 3. Hematology Segment-Revenue Forecast
  • 4. Hematology Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. Hematology Segment-Competitive Environment
  • 8. Hematology Segment-Installed Base
  • 9. Hematology Segment-Installed Base (continued)
  • 10. Hematology Segment-Product List
  • 11. Hematology Segment-Product List (continued)

11. CLINICAL MICROBIOLOGY SEGMENT BREAKDOWN

Clinical Microbiology Segment Breakdown

  • 1. Clinical Microbiology Segment-Overview
  • 2. Clinical Microbiology Segment-Market Engineering Measurements
  • 3. Clinical Microbiology Segment-Revenue Forecast
  • 4. Clinical Microbiology Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. Clinical Microbiology Segment-Competitive Environment
  • 8. Clinical Microbiology Segment-Technology Trends

12. HEMOSTASIS SEGMENT BREAKDOWN

Hemostasis Segment Breakdown

  • 1. Hemostasis Segment-Overview
  • 2. Hemostasis Segment-Market Engineering Measurements
  • 3. Hemostasis Segment-Revenue Forecast
  • 4. Hemostasis Segment-Revenue Forecast Discussion
  • 5. Competitive Analysis-Market Share
  • 6. Market Share Analysis
  • 7. Hemostasis Segment-Competitive Environment
  • 8. Hemostasis Segment-Tests
  • 9. Hemostasis Segment-Product List
  • 10. Hemostasis Segment-Product List (continued)

13. TISSUE DIAGNOSTICS SEGMENT BREAKDOWN

Tissue Diagnostics Segment Breakdown

  • 1. Tissue Diagnostics Segment Overview
  • 2. Tissue Diagnostics Segment Overview (continued)
  • 3. Tissue Diagnostics Segment-Market Engineering Measurements
  • 4. Tissue Diagnostics Segment-Revenue Forecast
  • 5. Tissue Diagnostics Segment-Revenue Forecast by Subsegment
  • 6. Tissue Diagnostics Segment-Revenue Forecast Discussion
  • 7. Competitive Analysis-Market Share
  • 8. Competitive Analysis-Market Share (continued)
  • 9. Competitive Structure

14. REGIONAL BREAKDOWN

Regional Breakdown

  • 1. Total IVD Market-Percent Revenue Forecast by Region
  • 2. Total IVD Market-Regional Growth
  • 3. IVD Market-US Revenue Forecast
  • 4. IVD Market-Western Europe Revenue Forecast
  • 5. IVD Market-Asia-Pacific and China Revenue Forecast
  • 6. IVD Market-Brazil Revenue Forecast
  • 7. IVD Market-Eastern Europe Revenue Forecast
  • 8. IVD Market-Rest of World Revenue Forecast

15. THE LAST WORD

The Last Word

  • 1. The Last Word-Three Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. Legal Disclaimer

16. APPENDIX

Appendix

  • 1. List of Other Companies-Total Market Level
  • 2. List of Other Companies-Segment Level
  • 3. List of Other Companies-US Tissue Diagnostics Segment
  • 4. Associated Multimedia
  • 5. Associated Multimedia (continued)
  • 6. Methodology
  • 7. Learn More-Next Steps

List of Exhibits

  • Total IVD Market: Market Engineering Measurements, Global, 2013
  • Total IVD Market: Market Segmentation, Global, 2013
  • Total IVD Market: Key Market Drivers, Global, 2014-2017
  • Total IVD Market: Key Market Restraints, Global, 2014-2017
  • Total IVD Market: Drivers for Emerging Markets, Global, 2014-2017
  • Total IVD Market: Restraints for Emerging Markets, Global, 2014-2017
  • Total IVD Market: Market Engineering Measurements, Global, 2013
  • Total IVD Market: Revenue Forecast, Global, 2012-2017
  • Total IVD Market: Percent of Sales, Global, 2013
  • Total IVD Market: Company Market Share Analysis of Top 12 Participants, Global, 2013
  • Total IVD Market: Competitive Structure, Global, 2013
  • Total IVD Market: Analysis of Key Mergers and Acquisitions, Global, 2013
  • Immunochemistry Segment: Market Engineering Measurements, Global, 2013
  • Immunochemistry Segment: Revenue Forecast, Global, 2012-2017
  • Immunochemistry Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Immunochemistry Segment: Competitive Structure, Global, 2013
  • Immunochemistry Segment: Installed Base, Global, 2013
  • Immunochemistry Segment: Number of Immunochemistry Analyzer Models and Configurations, Global, 2013
  • Immunochemistry Segment: List of Immunochemistry Analyzers, Global, 2013
  • Immunochemistry Segment: Common Clinical Chemistry Tests, Global, 2013
  • Immunochemistry Segment: Common Immunoassay Tests, Global, 2013
  • SMBG Segment: Market Engineering Measurements, Global, 2013
  • SMBG Segment: Revenue Forecast, Global, 2012-2017
  • SMBG Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • SMBG Segment: Competitive Structure, Global, 2013
  • SMBG Segment: Product List, Global, 2013
  • POCT Segment: Market Engineering Measurements, Global, 2013
  • POCT Segment: Revenue Forecast, Global, 2012-2017
  • POCT Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • POCT Segment: Competitive Structure, Global, 2013
  • Molecular Diagnostics Segment: Market Engineering Measurements, Global, 2013
  • Molecular Diagnostics Segment: Revenue Forecast, Global, 2012-2017
  • Molecular Diagnostics Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Molecular Diagnostics Segment: Competitive Structure, Global, 2013
  • Molecular Diagnostics Segment: Selection of FDA-cleared or -approved Tests, Global, 2013
  • Molecular Diagnostics Segment: Automated Molecular Platforms that Integrate Pre-analytical and Analytical Steps, Global, 2013
  • Molecular Diagnostics Segment: NGS Products, Global, 2013
  • Molecular Diagnostics Segment: Automated Molecular Platforms, Global, 2013
  • Hematology Segment: Market Engineering Measurements, Global, 2013
  • Hematology Segment: Revenue Forecast, Global, 2012-2017
  • Hematology Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Hematology Segment: Competitive Structure, Global, 2013
  • Hematology Segment: Installed Base, Global, 2013
  • Hematology Segment: Installed Base Split, Global, 2013
  • Hematology Segment: Hematology Products, Global, 2013
  • Clinical Microbiology Segment: Market Engineering Measurements, Global, 2013
  • Clinical Microbiology Segment: Revenue Forecast, Global, 2012-2017
  • Clinical Microbiology Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Clinical Microbiology Segment: Competitive Structure, Global, 2013
  • Clinical Microbiology Segment: Technology Trends, Global, 2011-2015
  • Hemostasis Segment: Market Engineering Measurements, Global, 2013
  • Hemostasis Segment: Revenue Forecast, Global, 2012-2017
  • Hemostasis Segment: Ranking of Key Participants Based on Market Share, Global, 2013
  • Hemostasis Segment: Competitive Structure, Global, 2013
  • Hemostasis Segment: Hemostasis Tests, Global, 2013
  • Hemostasis Segment: Hemostasis Analyzers, Global, 2013
  • Tissue Diagnostics Segment: Market Engineering Measurements, Global, 2013
  • Tissue Diagnostics Segment: Revenue Forecast, Global, 2012-2017
  • Tissue Diagnostics Segment: Revenue Forecast by Subsegment, Global, 2012-2017
  • Tissue Diagnostics Segment: Percent of Sales, United States, 2013
  • Tissue Diagnostics Segment: Percent of Sales, Western Europe 2013
  • Tissue Diagnostics Segment: Competitive Structure, Global, 2013
  • Total IVD Market: Percent Revenue by Region, Global, 2012-2017
  • Total IVD Market: Growth by Region, Global, 2012-2017
  • IVD Market: Revenue Forecast, United States, 2012-2017
  • IVD Market: Revenue Forecast, Western Europe, 2012-2017
  • IVD Market: Revenue Forecast, Asia-Pacific and China, 2012-2017
  • IVD Market: Revenue Forecast, Brazil, 2012-2017
  • IVD Market: Revenue Forecast, Eastern Europe, 2012-2017
  • IVD Market: Revenue Forecast, Rest of World, 2012-2017
Back to Top